top of page
Lily
CHEMOTHERAPY INDUCED HAIR LOSS
Lily
Technology aimed
at reducing hair loss
in chemotherapy patients
Hair loss is one of the most difficult aspects of cancer treatment. Chemotherapy attacks fast dividing cells, including hair cells, causing rapid hair loss within weeks of starting treatment.
Technology
Designed to use low-level compression therapy on the surface of the scalp.
Next steps
Lily is currently entering clinical trials in Europe. It is not released for commercial use.
Lilac
CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
Lilac
Technology aimed
to reduce the
onset of peripheral neuropathy
Chemotherapy induced peripheral neuropathy (CIPN) is the loss of sensory and motor function caused by nerve damage associated with chemotherapy.
Technology
Flexible low level compression therapy applied to the hands and feet.
Next steps
Lilac is currently in the prototype development phase, and is not released for commercial use.
bottom of page